For patients with biochemical recurrent prostate cancer, prostate-specific membrane antigen positron emission tomography has the potential to improve long-term outcomes. A new study tested this theory.
Which patients with high-risk prostate cancer are less likely to receive evidence-based care?
A new study investigates the utility of whole-body magnetic resonance imaging for detecting lymph and bone metastases in those with high-risk prostate cancer.